Acumen Pharmaceuticals Stock Return On Equity

ABOS Stock  USD 4.10  0.35  9.33%   
Acumen Pharmaceuticals fundamentals help investors to digest information that contributes to Acumen Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Acumen Stock. The fundamental analysis module provides a way to measure Acumen Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acumen Pharmaceuticals stock.
Return On Equity is likely to gain to -0.19 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Acumen Return On Equity Analysis

Acumen Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Acumen Pharmaceuticals Return On Equity

(0.19)

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Acumen Pharmaceuticals Return On Equity

    
  -0.2  
Most of Acumen Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acumen Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Acumen Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Acumen Pharmaceuticals is extremely important. It helps to project a fair market value of Acumen Stock properly, considering its historical fundamentals such as Return On Equity. Since Acumen Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Acumen Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Acumen Pharmaceuticals' interrelated accounts and indicators.
0.890.990.96-0.73-0.950.94-0.88-0.550.930.870.080.961.00.980.760.660.720.82
0.890.830.79-0.55-0.880.87-0.91-0.210.70.830.480.790.890.840.830.730.80.86
0.990.830.97-0.76-0.940.94-0.83-0.640.960.86-0.060.970.990.990.710.610.670.8
0.960.790.97-0.75-0.960.93-0.86-0.660.950.9-0.111.00.960.960.70.660.640.76
-0.73-0.55-0.76-0.750.63-0.840.780.33-0.83-0.50.19-0.75-0.77-0.83-0.14-0.05-0.07-0.49
-0.95-0.88-0.94-0.960.63-0.930.860.61-0.85-0.98-0.05-0.96-0.95-0.91-0.83-0.79-0.78-0.88
0.940.870.940.93-0.84-0.93-0.91-0.50.870.870.030.930.960.960.640.540.570.87
-0.88-0.91-0.83-0.860.780.86-0.910.19-0.8-0.78-0.32-0.86-0.9-0.89-0.61-0.57-0.56-0.71
-0.55-0.21-0.64-0.660.330.61-0.50.19-0.63-0.620.69-0.66-0.54-0.54-0.44-0.41-0.4-0.51
0.930.70.960.95-0.83-0.850.87-0.8-0.630.74-0.180.950.940.960.530.480.50.62
0.870.830.860.9-0.5-0.980.87-0.78-0.620.740.040.90.870.810.870.840.820.91
0.080.48-0.06-0.110.19-0.050.03-0.320.69-0.180.04-0.110.060.00.340.310.380.14
0.960.790.971.0-0.75-0.960.93-0.86-0.660.950.9-0.110.960.960.70.660.640.76
1.00.890.990.96-0.77-0.950.96-0.9-0.540.940.870.060.960.990.720.630.680.82
0.980.840.990.96-0.83-0.910.96-0.89-0.540.960.810.00.960.990.640.530.590.78
0.760.830.710.7-0.14-0.830.64-0.61-0.440.530.870.340.70.720.640.960.990.82
0.660.730.610.66-0.05-0.790.54-0.57-0.410.480.840.310.660.630.530.960.950.68
0.720.80.670.64-0.07-0.780.57-0.56-0.40.50.820.380.640.680.590.990.950.76
0.820.860.80.76-0.49-0.880.87-0.71-0.510.620.910.140.760.820.780.820.680.76
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Acumen Total Stockholder Equity

Total Stockholder Equity

143.2 Million

At this time, Acumen Pharmaceuticals' Total Stockholder Equity is comparatively stable compared to the past year.
Based on the latest financial disclosure, Acumen Pharmaceuticals has a Return On Equity of -0.2044. This is 99.15% lower than that of the Biotechnology sector and 99.44% lower than that of the Health Care industry. The return on equity for all United States stocks is 34.06% lower than that of the firm.

Acumen Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acumen Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Acumen Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Acumen Pharmaceuticals by comparing valuation metrics of similar companies.
Acumen Pharmaceuticals is currently under evaluation in return on equity category among related companies.

Acumen Fundamentals

About Acumen Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Acumen Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acumen Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acumen Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Return On Equity(0.20)(0.19)

Pair Trading with Acumen Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acumen Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Acumen Stock

  0.69MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Acumen Stock

  0.67TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.55KA Kineta Inc Report 29th of March 2024 PairCorr
  0.54VBIV VBI Vaccines Financial Report 20th of May 2024 PairCorr
The ability to find closely correlated positions to Acumen Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acumen Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acumen Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acumen Pharmaceuticals to buy it.
The correlation of Acumen Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acumen Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acumen Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acumen Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Acumen Pharmaceuticals is a strong investment it is important to analyze Acumen Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Acumen Pharmaceuticals' future performance. For an informed investment choice regarding Acumen Stock, refer to the following important reports:
Check out Acumen Pharmaceuticals Piotroski F Score and Acumen Pharmaceuticals Altman Z Score analysis.
For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Acumen Stock analysis

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bonds Directory
Find actively traded corporate debentures issued by US companies
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Acumen Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.11)
Revenue Per Share
0.033
Return On Assets
(0.15)
Return On Equity
(0.20)
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acumen Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.